| |
European Neuropsychopharmacology provides a medium for the prompt publication of articles in the
field of neuropsychopharmacology in its broadest sense.
Types of Papers:
Full length Research Papers of original experimental
or clinical research max 4000 words (including tables and legends to figures) and more than 30 references; Short Communications: same
as full length research max 2000 words; Reviews on specialised topics no words limit. Letters to the Editor can be related or not to
material published in the journal but are limited to 300 words and 5 references.
A covering letter must accompany all submissions
to European Neuropsychopharmacology whereby it is understood to imply that the data contained therein has not previously been
published and that they have been approved by the responsible authorities in the laboratory where the work was carried out. Manuscripts
submitted under multiple authorship are reviewed under the assumption that all listed authors concur with the submission and have approved
the final manuscript. If accepted, the paper shall not be published either whole or in part elsewhere without the consent of the Publisher.
Submission of Manuscripts
The submission to and peer review process of European Neuropsychopharmacology proceeds
totally online. To submit your article, please visit  http://ees.elsevier.com/eurneuropsychopharmacol and you will be guided
stepwise through the creation and uploading of the various files. Once the uploading is done, the system automatically generates an electronic
(PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and request for revisions, will be
processed through the system and will reach the corresponding author by e-mail.
The
Author Information
box to the right
of the page provides further relevant information.
Authors may send queries concerning the submission process or journal procedures
to the Editor-in-Chief:
Michael Davidson MD
Professor and Chairman
Department of Psychiatry
Tel Aviv University
Cellular phone +972 526666565
Email: ENP@elsevier.com
Organisation of the Manuscript
Only submissions
in English will be considered. The title page should include: the title, the name(s) and affiliation(s) of the author(s), and address
for correspondence, and telephone numbers for editorial queries.
All articles should include an Abstract (a single paragraph of no
more than 250 words), and 3-6 key words taken from Index Medicus for abstracting and indexing purposes.
The text should be ordered
under the following headings: 1. Introduction, 2. Experimental procedures, 3. Results, 4. Discussion, Author Disclosures (see separete
section on this), References.
NEW - Supplementary data
European Neuropsychopharmacology now also accepts electronic
supplementary material (e-components) to support and enhance presentation of your scientific research. Supplementary files offer the
Author additional possibilities to publish supporting applications, movies, animation sequences,high-resolution images, background datasets,
sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier
Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted
material is
directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic
format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit
our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
At their discretion authors are also invited
to submit 5-15 Power Point slides summarizing in words, tables or figures their paper. The slides will be posted on the journal site
and readers will have the opportunity to download and use the slides for didactical purposes only.
Author Disclosure
Role of Funding Source. Authors are kindly requested to briefly describe the role of the study sponsor(s), if any, in study design;
in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
If the funding source(s) had no such involvement, authors should so state.
eg, Funding for this study was provided by NIMH Grant
XXXXXXX; the NIMH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the
report; and in the decision to submit the paper for publication.
Following the Role of the Funding Source text, authors
are required to declare their individual contribution to the manuscript under a subheading Contributors.
eg, Author X
designed the study and wrote the protocol. Author Y managed the literature searches and analyses. Authors X and Z undertook the statistical
analysis, and author W wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
The third aspect of the Journal's new policy concerns the Conflict of Interest. ALL authors are requested to disclose any
actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations
within three (3) years of beginning the work submitted that could inappropriately influence, or be perceived to influence, their work.
Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership (except
for personal investment purposes equal to the lesser of one percent (1%) or USD 5000), honoraria, paid expert testimony, patent applications,
registrations, and grants. If there are no conflicts of interest, authors should state that there are none.
eg, Author Y owns
shares in pharma company A. Author X and Z have consulted for pharma company B. All other authors declare that they have no conflicts
of interest.
Finally, before the references, the Journal will publish Acknowledgements, in a separate section, and not
as a footnote on the title page.
eg, We thank Mr A, who kindly provided the data necessary for our analysis, and Miss B, who
assisted with the preparation and proof-reading of the manuscript.
NB. During the online submission process the author
will be prompted to upload these four mandatory author disclosures as separate items. They will be automatically incorporated
in the PDF builder of the online submission system. Please do not include in the main manuscripts.
Papers that do not conform
to the general criteria for publication in European Neuropsychopharmacology will be returned immediately to authors to avoid
unnecessary delay in submission elsewhere.
Figures and Photographs
Figures and Photographs of good quality should be
submitted online as a separate file. Please use a lettering that remains clearly readable even after reduction to about 66%. For every
figure or photograph, a legend should be provided. All authors wishing to use illustrations already published must first obtain the permission
of the author and publisher and/or copyright holders and give precise reference to the original work. This permission must include the
right to publish in electronic media.
Tables
Tables should be numbered consecutively with Arabic numerals and must be
cited in the text in sequence. Each table, with an appropriate brief legend, comprehensible without reference to the text, should be
typed on a separate page and uploaded online. Tables should be kept as simple as possible and wherever possible a graphical representation
used instead. Table titles should be complete but brief. Information other than that defining the data should be presented as footnotes.
Please refer to the generic Elsevier artwork instructions:
http://www.elsevier.com/artwork
References
Authors are responsible for the accuracy of the references. Only published articles and those in press (the journal should be stated)
may be included; unpublished results and personal communications should be cited as such in the text.
Text:
All citations
in the text should refer to:
Single author: the autor's name (without initials, unless there is ambiguity) and the year
of publication;
Two authors: both authors'names and the year of publication;
Three or more authors: first author's name
followed by "el al." and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should
be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995).
Kramer et al. (2000) have recently shown ...."
List:
References should be arranged first alphabetically and then further
sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters
"a", "b", "c", etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der
Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific article. J. Sci. Commun. 163, 51-59.
Reference to
a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New York.
Reference to a chapter in an
edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z.
(Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.
Nomenclature
Metric units must
be used throughout; laboratory units must be followed by SI (Systeme International) units. The generic name of the drug should be used
unless the specific trade name of the drug is directly relevant to the discussion. For receptor nomenclature, authors are referred to
the special supplement of Trends in Pharmacological Sciences devoted to this.
Ethics of experimentation Procedures involving experiments
on human subjects should be in accordance with the ethical standards of the Committee on Human Experimentation of the institution in
which the experiments were done or in accordance with the Helsinki Declaration of 1975. Procedures involving experimentation on animals
should be done in accordance with the guidelines of the institution in which the experiments were done.
Colour illustrations
online
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution.
Polaroid colour prints are not suitable.
If, together with your accepted article, you submit usable colour figures then Elsevier
will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g. ScienceDirect and other sites) regardless
of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive
information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print
or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artwork.
Please note: Because of technical complications which can arise by converting colour figures to "grey scale" (for the printed version
should you
not opt for colour in print) please submit in addition usable black and white versions of all the colour illustrations.
Copyright Transfer
Upon acceptance of an article, you will be asked to transfer copyright. This transfer will ensure the widest
possible dissemination of information. If excerpts from other copyrighted works are included in the submission, the author(s) must obtain
written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors
in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 238 7869, fax (+1) 215 238 2239, e-mail permissions@elsevier.com.
Requests for materials from other Elsevier publications may also be completed on-line via the Elsevier homepage http://www.elsevier.com/locate/permissions.
Ethics of Experimentation
Procedures involving experiments on human subjects should be in accordance with the ethical
standards of the Committee on Human Experimentation of the institution in which the experiments were done or in accordance with the Helsinki
Declaration of 1975. Procedures involving experimentation on animals should be done in accordance with the guidelines of the institution
in which the experiments were done.
Proofs
One set of proofs will be supplied to the author to check for type-setting
accuracy: no changes to the manuscript will be allowed at this stage. Elsevier will do everything possible to correct your article and
publish it accurately and without delay. It is important, therefore, to ensure that all author corrections are marked clearly on your
proofs and returned to us in one communication. No additional corrections are possible following receipt by Elsevier of the first set
of marked up proofs. In the interests of publication time, authors should respond as quickly as possible, preferably by e-mail.
Reprints
PDF offprints are provided free of charge. No reprints are provided free of charge. Reprints (50 copies minimum) can be ordered at quoted
prices on order forms sent out together with the proofs.
|
| |
|
